The maxillary sinus is a rare anatomic site for Hodgkin lymphoma, as only 1 such case has been previously reported in the literature. Nevertheless, we recommend that lymphoma be considered in the differential diagnosis of a mass that involves the maxillary sinus or any other unusual extranodal site in the head and neck. Lymphoma in a patient who presents with disease in an unusual site and without lymphadenopathy is difficult to diagnose. We report the case of a 60-year-old woman who presented with nasal congestion and obstruction. Examination revealed an abnormal-appearing mucosa involving the maxillary sinus. Subsequent evaluation led to a diagnosis of Hodgkin lymphoma. Because making such a diagnosis is difficult, close attention to radiologic and pathologic findings is important. Our review of the literature revealed that treatment commonly includes chemotherapy and radiotherapy, which yield excellent outcomes. The current standard of care for patients with similar-stage Hodgkin lymphoma at other sites can guide the treatment course for patients with extranodal Hodgkin lymphoma. Peterson et al, † 2012 1 I 42 Maxillary sinus * Mechlorethamine, vincristine, vinblastine, procarbazine, prednisone, and oxethazine. † Present case. Key: F/U = follow-up; MOPP = mechlorethamine, vincristine, procarbazine, and prednisone; CT = chemotherapy; RT = radiotherapy; NED = no evidence of disease; COPP = cyclophosphamide, vincristine, procarbazine, and prednisolone; NR = not reported; ABVD = doxorubicin, bleomycin, vinblastine, and dacarbazine. Volume 91, Number 1 www.entjournal.com  E19 Hodgkin lympHoma of tHe maxillary sinus: an unusual occurrence Type of treatment Outcome MOPP CT alone, NED RT alone, or CT/RT Combination CT* NED COPP CT NED RT alone (75%), Local recurrence, 7.7%; CT alone (25%) dissemination, 23% RT NED ABVD CT plus RT NED or RT alone RT NED CT alone (15%), 4 recurrences RT alone (15%), CT/RT (70%) ABVD CT with NED growth-factor support plus RT ine.
Introduction
Typically, Hodgkin lymphoma occurs concomitantly with cervical or mediastinal lymphadenopathy. Although extranodal sites are occasionally involved through direct extension from surrounding lymphadenopathy, Hodgkin lymphoma rarely occurs primarily as an extranodal entity, especially in the head and neck region. 1 We describe a case of extranodal Hodgkin lymphoma of the maxillary sinus. We also discuss its diagnosis and management, and we review the literature on this rare entity.
Case report
A 60-year-old woman presented to another facility with a history of nasal congestion and obstruction. During a septoplasty performed to relieve symptoms, an abnormal-appearing mucosa was noted in the right maxillary sinus. Histologic examination of an excisional biopsy specimen revealed no evidence of malignancy. The patient was then referred to our institution for further evaluation.
A review of systems indicated an excellent performance status with no weight loss, fevers, or night sweats. On physical examination, the right nasal cavity was found to be completely obstructed and the mucosa was markedly hypertrophied. The medial maxillary wall of the inferior turbinate bulged into the right nasal canal. A polypoid mass was seen emanating from the right middle meatus, and it occluded the nasal cavity. Examination with flexible laryngoscopy through the opposite naris detected no abnormalities. No lymphadenopathy or hepatosplenomegaly was noted.
Computed tomography (CT) of the sinuses showed a complete opacification of the right maxillary sinus; soft tissue occupied the right nasal passageway and extended into the nasopharynx, causing a deviation of the nasal septum ( figure 1 ). In addition, complete opacification of the right ethmoid sinus, frontal sinus, and sphenoid sinus was observed.
The patient underwent an extensive surgical resection, which involved a right anterior and posterior ethmoidectomy, a sphenoidotomy, a maxillary antrostomy, and a frontal sinusotomy with the removal of contents and an inferior turbinate reduction. The final pathologic findings were consistent with classic extranodal Hodgkin lymphoma of the mixed cellularity subtype. These findings included positivity for CD15 and CD30 and In patients with malignant tumors of the maxillary sinus, the most common histologic diagnoses are squamous cell carcinoma (39 to 62% of cases) and adenoid cystic carcinoma (12 to 22%). 1, 3, 4 Of all maxillary sinus malignancies, lymphoma occurs in less than 10% of cases. 1, 3, 4 The characteristics of non-Hodgkin lymphoma of the paranasal sinuses have been reviewed in several negativity for leukocyte-common antigen (figure 2, A). The Reed-Sternberg cells contained latent Epstein-Barr virus ( figure 2, B) .
The results of a complete blood count and chemistry panel, including measurement of the lactate dehydrogenase level, were within normal limits. A screening test was negative for human immunodeficiency virus. Several tests showed no lymphoma beyond the original site: CT of the chest, abdomen, and pelvis; positron-emission tomography; and a bone marrow biopsy.
The patient was diagnosed with extranodal stage IA Hodgkin lymphoma of the maxillary sinus. She was treated postoperatively with chemotherapy followed by involved-field radiotherapy. She received 3 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine with growth-factor support. Intensity-modulated radiotherapy was delivered with 6-MV photon beams to a total dose of 34 Gy in 20 fractions to the right paranasal area. No nodes were irradiated. After 42 months of posttherapy follow-up, the patient exhibited no evidence of residual or recurrent disease.
Discussion
The maxillary sinus is a rare anatomic site for the presence of Hodgkin lymphoma. Typically, lymphomas of the head and neck region appear as cervical lymphadenopathy. Patients who present with extranodal involvement usually have disease located in the Waldeyer tonsillar ring. Other sites of extranodal involvement are rare. Urquhart and Berg reviewed the records of 311 patients with head and neck lymphoma and found that 4% had extranodal Hodgkin lymphoma and 23% had extranodal non-Hodgkin lymphoma. 2 The other patients in that series presented with lymphadenopathy alone. published case series. [5] [6] [7] To the best of our knowledge, only 1 case of Hodgkin lymphoma that originated in the maxillary sinus has been previously reported in the literature. In that report, Shlansky-Goldberg et al described the case of a man who presented with a fixed infraorbital mass and cervical lymphadenopathy. 8 Imaging detected the mass occupying the maxillary sinus with involvement of the bony walls of the sinus and extension into the cheek and masseter muscle. The results of a biopsy analysis were consistent with nodular sclerosing Hodgkin lymphoma.
Shlansky-Goldberg et al also described several CT patterns that can help differentiate lymphoma of the maxillary sinus from more common histologic findings such as squamous cell carcinoma. 8 Involvement of multiple nodes-particularly the deep, middle, and lower cervical nodes-is more common in lymphoma. Involvement of the upper cervical or superficial nodes is more common in carcinoma of the maxillary sinus. Necrotic nodes are rarely (<5%) associated with Hodgkin disease. Bony expansion is a clinical feature that is associated with lymphoma of the maxillary sinus, whereas bony destruction is more often seen in cases of carcinoma.
Although few data exist on Hodgkin lymphoma of the maxillary sinus, the authors of several case reports have described the characteristics of extranodal Hodgkin lymphoma in surrounding structures, including the oropharynx, nasopharynx, parotid gland, thyroid gland, nasal antrum, and maxilla (table). [9] [10] [11] [12] [13] [14] [15] [16] Our review of the medical literature revealed that most patients with Hodgkin lymphoma that involved extranodal sites in the head and neck had received standard treatment with chemotherapy and radiotherapy, and this treatment approach resulted in excellent control rates. The chemotherapeutic regimens in these reports varied according to the years in which these patients were treated. Two chemotherapeutic regimens-ABVD and Stanford Vare currently recommended for Hodgkin lymphoma; the former, which our patient received, includes doxorubicin (Adriamycin), bleomycin, vinblastine, and dacarbazine, and the latter consists of mechlorethamine, vincristine, prednisone, doxorubicin, bleomycin, vinblastine, and etoposide.
In reports of cases in which radiation technique was discussed, the primary site of disease was irradiated with or without irradiation of the unilateral cervical nodes, bilateral cervical nodes, and supraclavicular nodes. [13] [14] [15] Radiation doses ranged from 30 to 50 Gy. The decision to include nodal levels in the radiation field was based on recommendations for nodal irradiation for the more common cancers at a particular primary site. For example, nodal irradiation for node-negative squamous cell carcinoma of the maxillary sinus is controversial. Therefore, nodal areas were not irradiated in our patient with Hodgkin lymphoma of the maxillary sinus.
In conclusion, a reasonable management approach for Hodgkin lymphoma of the maxillary sinus is to first obtain accurate pathologic and staging data. Treatment recommendations can then be based on the current standard of care for patients with similar-stage Hodgkin lymphoma at other sites.
